The Role of MTA Family Members in Feline Mammary Tumor
Faculty Mentor
Anait S. Levenson
Area of Research
Cancer Biology
Major
Veterinary Technology (B.S.), Pre-DVM
Description
INTRODUCTION: Feline mammary tumors (FMTs) are highly aggressive neoplasms, with 80–90% classified as malignant and often associated with poor prognosis. Despite their prevalence, the molecular mechanisms driving tumor progression are not fully understood. This study investigates key molecular determinants involved in FMT development, focusing on proliferation, angiogenesis, and metastasis through markers including Ki67, CD31, and metastasis-associated protein 1 (MTA1). Because many FMTs are hormone receptor-negative, identifying alternative molecular markers is important for improving diagnosis and treatment strategies.
METHOD: Immunohistochemistry (IHC) was performed on normal and tumor feline mammary tissue samples to evaluate protein expression. Tissue sections were stained with antibodies targeting MTA1 and Ki67 and analyzed at 20x and 40x magnifications. Expression levels were quantified using intensity grading and stain scoring based on frequency and staining intensity. Statistical comparisons between normal and tumor groups were conducted using t-tests. Additionally, MTA2 was examined through literature review to assess its potential role in metastasis and tumor progression.
RESULTS: Tumor samples showed increased expression of both MTA1 and Ki67 compared to normal tissue, indicating elevated proliferative and metastatic activity. Quantitative analysis revealed significantly higher staining intensity and frequency in tumor tissues (p < 0.0001).
DISCUSSION/CONCLUSION: These findings support the role of MTA1 in promoting tumor progression and suggest its value as a potential biomarker for FMT aggressiveness. Overall, this study highlights the importance of molecular characterization in understanding feline mammary tumors and provides insight into potential targets for future diagnostic and therapeutic approaches.
The Role of MTA Family Members in Feline Mammary Tumor
INTRODUCTION: Feline mammary tumors (FMTs) are highly aggressive neoplasms, with 80–90% classified as malignant and often associated with poor prognosis. Despite their prevalence, the molecular mechanisms driving tumor progression are not fully understood. This study investigates key molecular determinants involved in FMT development, focusing on proliferation, angiogenesis, and metastasis through markers including Ki67, CD31, and metastasis-associated protein 1 (MTA1). Because many FMTs are hormone receptor-negative, identifying alternative molecular markers is important for improving diagnosis and treatment strategies.
METHOD: Immunohistochemistry (IHC) was performed on normal and tumor feline mammary tissue samples to evaluate protein expression. Tissue sections were stained with antibodies targeting MTA1 and Ki67 and analyzed at 20x and 40x magnifications. Expression levels were quantified using intensity grading and stain scoring based on frequency and staining intensity. Statistical comparisons between normal and tumor groups were conducted using t-tests. Additionally, MTA2 was examined through literature review to assess its potential role in metastasis and tumor progression.
RESULTS: Tumor samples showed increased expression of both MTA1 and Ki67 compared to normal tissue, indicating elevated proliferative and metastatic activity. Quantitative analysis revealed significantly higher staining intensity and frequency in tumor tissues (p < 0.0001).
DISCUSSION/CONCLUSION: These findings support the role of MTA1 in promoting tumor progression and suggest its value as a potential biomarker for FMT aggressiveness. Overall, this study highlights the importance of molecular characterization in understanding feline mammary tumors and provides insight into potential targets for future diagnostic and therapeutic approaches.